Thursday, May 13
Bristol-Myers Squibb - Lunch Symposium, 12:30-14:00
Long-term Considerations in Initiating ART: Challenges and Solutions
Chair:
Stephen D Shafran, MD, FRCPC
Professor of Medicine, Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, AB
Faculty:
Jean-Guy Baril, MD
Clinique médicale du Quartier Latin, Montréal
Service de consultation-liaison VIH-SIDA, CHUM
Assistant professor, University of Montreal
Chair, Advisory Committee on the clinical management of people living with HIV-AIDS
Co-President of the Réseau SIDA-MI of the FRSQ, Montréal, Québec
Paul A. MacPherson MD, PhD, FRCPC
Assistant Professor, Division of Infectious Diseases, Ottawa Hospital, General Campus, Ottawa Health Research Institute, University of Ottawa, Ottawa, ON
When to begin antiretroviral treatment (ART), what are the considerations for long-term therapy and how best to individualize treatment are challenges facing physicians who treat the HIV-infected patient in 2010. As survival increases in this patient population, physicians increasingly have to deal with numerous comorbid conditions for which the evidence on how best to manage is unclear. Using an interactive case-study format, faculty will review the relevant data and guidelines to provide an overview of the evidence-based treatment for a selection of patient profiles. Audience members will be encouraged to discuss concerns and challenges in the treatment of these patient profiles, providing opportunity for practical solutions and feedback on the initiation of ART.
Friday, May 14
ViiV Healthcare - Lunch Symposium, 12:30-14:00
Experience with HIV Tropism Testing using Genotype Methods
Chair:
Sharon L Walmsley, FRCPC, MD, MSc
Professor of Medicine, University of Toronto
Director of Clinical Research, Immunodeficiency Clinic, Toronto Hospital
Toronto, Ontario
Speakers:
Richard Harrigan, PhD
Director, Research Laboratories, BC Centre for Excellence in HIV/AIDS
Vancouver, BC
Mark A Wainberg, PhD
Director of the McGill University AIDS Centre, Montreal Jewish General Hospital
Professor of Medicine and Microbiology, McGill University
Montreal, Quebec
Unlike HIV medications that act on HIV directly, CCR5 entry inhibitors belong to a new class of drugs that act on the human T-cell, changing it in such a way that HIV is unable to bind and thereby continue the replication process.
Come and learn more on how CCR5 entry inhibitors are used in Canada and how it will change the future of HIV treatment.
Abbott Laboratories, Ltd -
Afternoon Symposium, 17:00-18:15
The HIV Management Collective: Strategies and Support
Panel Members:
Adriana Carvalhal, MD, PhD
Assistant Professor - Depart. Psychiatry & Behavioural Neuroscience
McMaster University, Hamilton, Ontario
LaVerne Monette
Executive Director of the Ontario Aboriginal HIV/AIDS Strategy, Toronto, Ontario
Ken Kasper, MD
Director of the Manitoba HIV program, Winnipeg, Manitoba
Nancy Sheehan, BPharm, MSc
Pharmacist, Immunodeficiency Service, Montréal Chest Institute
Assistant Clinical Professor, Faculté de Pharmacie, Université de Montréal
Montréal, Québec
Kecia Larkin
Speaker, Victoria, British Columbia
Kecia is from the Kwa'kwa'ka'wakw and Piikani First Nations of British Columbia and Alberta, and resides in Victoria, BC. Kecia has worked in many capacities of the Aboriginal HIV/AIDS Movement for over 20 years and continues to contribute her experience in a wide variety of capacities.
Join us as we explore the challenges faced by persons living with HIV in a unique, intimate and interactive session. Learn about key factors affecting quality of life through the perspectives of patients and an interdisciplinary health care team.
Focused on Aboriginal Peoples (First Nations, Metis and Inuit) living with HIV, this session will allow us to learn and grow.
Together we will discuss the epidemiology of neurocognitive disorders, psychosocial issues, and the reality of stigmatization as we work towards positive outcomes for persons living with HIV.
Saturday, May 15
Merck Frosst Canada Limited - Breakfast Symposium, 7:00-8:45
HIV Therapy – Tailoring Treatment for the Patient
Facilitator:
Jonathan Angel, M.D., FRCPC
Senior Scientist, Ottawa Hospital Research Institute
Professor of Medicine, University of Ottawa
The Ottawa Hospital - General Campus
Speakers:
Mark Nelson, M.A., M.B.B.S., MRCP
Service Director, HIV Directorate & Deputy Director of Research, Chelsea and Westminster Hospital
Trustee, St. Stephen’s AIDS Trust
Réjean Thomas, C.M., C.Q., M.D., LMCC, DHC
President and Clinical Physician, Clinique médicale l'Actuel
Honorary President, Médecins du Monde Canada
Centre hospitalier universitaire de Montréal (CHUM)
Associate Member, McGill University AIDS Centre
As new antiretroviral drugs are developed and more is known about existing therapies, there is a continuing need to update treatment strategies and therapeutic approaches. Advances will also come from using new or available drugs centered on the patient’s values, preferences and expressed needs.
In this symposium we will look at new options for therapy in patients living with HIV and examine the concept of optimizing patient care. We will also answer the question, “How do I keep the patient’s needs at the centre of my therapeutic decision-making?” by looking at best practices in a unique patient-centred clinic model.
Tibotec - Lunch Symposium, 12:30-14:00
The Hero’s Journey – Making Informed Choices about HIV Treament Regimens
With:
Dr. Marianne Harris, MD, CCFP
Clinical Research Advisor, St. Paul’s AIDS Research Program, Vancouver BC
Clinical Assistant Professor, Department of Family Practice, Faculty of Medicine, UBC
Linda Robinson
HIV Pharmacist, Windsor Regional Hospital, Windsor ON
Eric Johnston
Speaker, BSc. Nursing, Halifax NS
Stephen Alexander
Moderator, Ottawa ON
Open communication between patients and HCPs is critical in HIV care for treatment success, and may directly impact patient adherence and symptom management. In a dynamic format, including role-plays, we will follow the journey of an HIV patient while navigating the health care system. Challenges and triumphs at the patient/health-care provider interface will be explored, while offering tools for patients to get the most from medical visits and providing motivational interviewing strategies for Health Care Professionals.
|
